Search

In the General Assembly of AseBio, new vice-presidents have also been elected: Carlos Buesa, CEO of Oryzon (First Vice-presidency); Cristina Nadal, Policy Executive Director of MSD Spain (Second Vice

The list, comprised of 268 drugs, is an important tool to support the EU's efforts to ensure the security of the supply chain and prevent shortages of critical medications. Over the last 40 years

The purpose behind our request for the creation of the High Commissioner is to strengthen Spain's commitment to deep technologies at a critical moment for Europe's strategic autonomy.

The biotech sector provides cross-cutting solutions ranging from the diagnosis, research, and treatment of infectious diseases to the development of innovative preventive and therapeutic strategies

Beyond the direct impact of biotechnology on human health and the planet, investment in science and biotechnology has a direct relationship with the competitiveness, sustainability, and economic

The President of the Generalitat de Catalunya, Pere Aragonès i Garcia, and the General Manager of Amgen and member of the Board of Directors of AseBio and the Board of Trustees of Biocat, Fina Lladós

Ensuring food security and mitigating the impacts of climate change will not be possible without innovation in agriculture. Through food waste and the insect industry, proteins are being produced in a

The majority of biotechnology companies are small and micro-enterprises that do not have products on the market and do not generate the necessary resources to finance their activities. There is an

The sector has radically transformed the discovery of new drugs and therapeutic solutions. Worldwide, there are over 300 approved medications for approximately 250 indications and a thousand molecules

The new edition of the international flagship event in the biotech sector will take place in Barcelona from September 26 to 28, in collaboration with Biocat, the Government of Catalonia, and the

The European project ShapingBio, created with the aim of better understanding and gaining knowledge of the innovation ecosystem in the European bioeconomy sector, will be present at BIOSPAIN. Under

During the Presidency of the Council of the European Union, Spain will lead the dialogue on these critical policies for European patients, food safety, and the green transition. "We need to find a

Over 30 innovative biotech companies possess the comprehensive capabilities to develop advanced therapies, from initial R&D through manufacturing, efficient transfer and distribution

AseBio gave an advance look at these figures at an event celebrating the 20th anniversary of BIOSPAIN, two decades over which a total of €1.2 billion has been invested in the biotechnology sector

The presentation took place at the Meta Space in Madrid with Secretary General for Innovation Teresa Riesgo and AseBio Chairwoman Ana Polanco The analysis highlights that 60% of all people who work at

The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the

For International Day of Women and Girls in Science, 14 women from 12 companies will host young female students to encourage them to go into science and innovation and show them the different

BIOSPAIN 2023 expects to bring together over 1,500 professionals from 30 countries around the world in Barcelona, opening up business opportunities with more than 2,000 one-to-one meetings and 50